The use of a morcellator device during a hysterectomy or fibroid removal procedure has been linked to:
The FDA has discouraged the use of laparoscopic power morcellation for removal of uterus or uterine fibroids. If you or a loved one has been diagnosed with cancer after a power morcellator was used during a hysterectomy or myomectomy, you may be entitled to financial compensation.
Laparoscopic Power Morcellators are medical devices that doctors use during minimally invasive surgeries for hysterectomies (removal of the uterus) or myomectomies (removal of uterine fibroids). Morcellation refers to the process of tissue being made into smaller pieces or fragments through small incision areas.
Use of a power Morcellator device has been linked to uterine cancer, uterine sarcoma and leiomyosarcoma.
Some women have experienced or have been diagnosed with cancer caused by the Morcellator devices ineffectiveness of removing 100% of fibroids or tissue. In many cases the cancer was discovered it in it’s late stages making it potentially harder to fight.
Many women are now filing claims against Ethicon Inc., a division of Johnson & Johnson, and the manufacturer of the Power Morcellator. The Morcellator has the potential of leaving cancerous fragments behind and making the spread of the cancer cells to other parts of the body possible.
FDA estimates that 1 in 350 women who undergo a procedure with a power Morcellator may have undiagnosed uterine cancer. The FDA issued a safety warning in April 2014 against using this device in uterine and fibroid removal surgeries.
Ethicon Inc. has now stopped all sales of the device after the FDA released the warning in April 2014. Power Morcellator lawsuits are currently in the beginning stages and many lawyers are now accepting claims. If you or a loved one have been diagnosed with uterine cancer, uterine sarcoma or leiomyosarcoma after the use of a Power Morcellator device ACT NOW. You may be entitled to the financial compensation you deserve.